Working Mechanisms and Effectiveness of IV Ketamine-assisted Psychotherapy on Depression in TRD Clients

Recruiting Observational Study
Treatment Resistant Depression
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Observational
Participants needed
120 (estimated)
Sponsor
Senz · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Ketamine-Assisted Psychotherapy (KAP) is an innovative treatment that combines intravenous ketamine with psychotherapy in a carefully monitored clinical setting. At Senz, this treatment is being evaluated in an open-label clinical trial for individuals with persistent depression who have not responded sufficiently to previous treatments. The combination of ketamine, psychological support, and inte…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults (18 years and older) * TRD * A MADRS score above the established clinical cut-off, indicating clinically significant depressive symptoms * Insufficient response to at least two adequate antidepressant treatment trials and one evidence-based psychotherapy, or failure to …
Contacts

Rutger Engels, dr

+31 343 235300

r.engels@senzggz.nl

CONTACT

karlijn kindt, dr

+31343 235300

k.kindt@senzggz.nl

CONTACT